Stroke prevention: Might vitamin D be safer than statins?

Internal and Emergency Medicine

Volumn 7, Issue SUPPL. 2, 2012, Pages 89-90

  Mascitelli, Luca ^a   Goldstein, Mark R ^b   Grant, William B ^b  

^a Comando Brigata Alpina Julia Medical Service ^*  (Italy)

^b Fountain Medical Court ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMAN; LETTER;

BRAIN ISCHEMIA; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; STROKE;

EID: 84865729566     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0652-1     Document Type: Letter

References (5)

1. Paliani U, Ricci S (2011) The role of statins in stroke. Intern Emerg Med (Epub ahead of print).
2. Mascitelli L, Pezzetta F, Goldstein MR (2010) Statin therapy in the secondary prevention of cerebrovascular events: is it really beneficial in clinical practice? Med Hypotheses 74: 398.
3. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355: 549-559.
4. Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB (2008) Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke 39: 497-502.
5. Pilz S, Tomaschitz A, Drechsler C, Zittermann A, Dekker JM, März W (2011) Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets 12: 88-96.